Literature DB >> 30576644

AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.

Cynthia W Ko1, Siddharth Singh2, Joseph D Feuerstein3, Corinna Falck-Ytter4, Yngve Falck-Ytter5, Raymond K Cross6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30576644      PMCID： PMC6858922          DOI： 10.1053/j.gastro.2018.12.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  151 in total

1.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

Authors:  Noortje G Rossen; Susana Fuentes; Mirjam J van der Spek; Jan G Tijssen; Jorn H A Hartman; Ann Duflou; Mark Löwenberg; Gijs R van den Brink; Elisabeth M H Mathus-Vliegen; Willem M de Vos; Erwin G Zoetendal; Geert R D'Haens; Cyriel Y Ponsioen
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

2.  Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study.

Authors:  Nobuo Hiwatashi; Yasuo Suzuki; Keiichi Mitsuyama; Akihiro Munakata; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2010-09-29       Impact factor: 7.527

3.  Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.

Authors:  G d'Albasio; F Pacini; E Camarri; A Messori; G Trallori; A G Bonanomi; G Bardazzi; M Milla; S Ferrero; M Biagini; S Quaranta; A Amorosi
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

4.  Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.

Authors:  W Kruis; L Jonaitis; J Pokrotnieks; T L Mikhailova; M Horynski; M Bátovský; Y S Lozynsky; Y Zakharash; I Rácz; K Kull; A Vcev; M Faszczyk; K Dilger; R Greinwald; R Mueller
Journal:  Aliment Pharmacol Ther       Date:  2010-12-08       Impact factor: 8.171

5.  Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.

Authors:  P Gionchetti; F Rizzello; A Venturi; M Ferretti; C Brignola; M Miglioli; M Campieri
Journal:  Dis Colon Rectum       Date:  1998-01       Impact factor: 4.585

6.  Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.

Authors:  J R Green; A J Lobo; C D Holdsworth; R J Leicester; J A Gibson; G D Kerr; H J Hodgson; K J Parkins; M D Taylor
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

7.  Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.

Authors:  A Nilsson; A Danielsson; R Löfberg; P Benno; L Bergman; O Fausa; J Florholmen; A L Karvonen; S Kildebo; B Kollberg
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

8.  Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.

Authors:  P Miner; S Hanauer; M Robinson; J Schwartz; S Arora
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 9.  Are there any differences in the efficacy and safety of different formulations of Oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? evidence from cochrane reviews.

Authors:  Brian G Feagan; Nilesh Chande; John K MacDonald
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

10.  Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.

Authors:  Geert D'Haens; William J Sandborn; Karen Barrett; Ian Hodgson; Paul Streck
Journal:  Am J Gastroenterol       Date:  2012-05-08       Impact factor: 10.864
View more
  49 in total

Review 1.  Maneuvering Clinical Pathways for Ulcerative Colitis.

Authors:  Christopher M Johnson; Catherine D Linzay; Themistocles Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2019-09-05

2.  Moving from efficacy to effectiveness: budesonide multimatrix in ulcerative colitis.

Authors:  Fernando Magro; Maria Manuela Estevinho
Journal:  United European Gastroenterol J       Date:  2019-09-22       Impact factor: 4.623

3.  No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy.

Authors:  Siddharth Singh; Jihoon Kim; Wenhong Zhu; Parambir S Dulai; William J Sandborn; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2020-06-23       Impact factor: 8.171

4.  Analysis of the Long-Term Prognosis in Japanese Patients with Ulcerative Colitis Treated with New Therapeutic Agents and the Correlation between Prognosis and Disease Susceptibility Loci.

Authors:  Kasumi Hishinuma; Rintaro Moroi; Daisuke Okamoto; Yusuke Shimoyama; Masatake Kuroha; Hisashi Shiga; Yoichi Kakuta; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  Inflamm Intest Dis       Date:  2021-09-02

5.  Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?

Authors:  Hassan Ghoz; Alex Kesler; Sanne A Hoogenboom; Filippo Gavi; Bhaumik Brahmbhatt; John Cangemi; Paul T Kröner
Journal:  J Gastrointest Surg       Date:  2019-12-03       Impact factor: 3.452

6.  AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.

Authors:  Siddharth Singh; Jessica R Allegretti; Shazia Mehmood Siddique; Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

7.  Predictors of Inadequate Response to Budesonide Multimatrix in Real-World Patients with Ulcerative Colitis.

Authors:  Sydney Greenberg; Hans H Herfarth; Edward L Barnes
Journal:  Inflamm Intest Dis       Date:  2019-07-10

8.  Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis.

Authors:  Christopher Ma; Jenny Jeyarajah; Leonardo Guizzetti; Claire E Parker; Siddharth Singh; Parambir S Dulai; Geert R D'Haens; William J Sandborn; Brian G Feagan; Vipul Jairath
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-03       Impact factor: 11.382

9.  Trends in Morbidity and Mortality Following Colectomy Among Patients with Ulcerative Colitis in the Biologic Era (2002-2013): A Study Using the National Inpatient Sample.

Authors:  Babatunde Olaiya; Benjamin D Renelus; Mikolaj Filon; Sumona Saha
Journal:  Dig Dis Sci       Date:  2020-07-16       Impact factor: 3.199

Review 10.  The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management.

Authors:  Simon J Hong; Seymour Katz
Journal:  Therap Adv Gastroenterol       Date:  2021-07-03       Impact factor: 4.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.